Lista de obras -

A Study of Hypermethylated Circulating Tumor DNA as a Universal Colorectal Cancer Biomarker

artículo científico publicado en 2016

BRAF V600E mutations in bile duct adenomas.

artículo científico publicado en 2014

Bile duct adenoma should not be designated as a reactive process.

artículo científico publicado en 2015

Constitutive autophagy contributes to resistance to TP53-mediated apoptosis in Epstein-Barr virus-positive latency III B-cell lymphoproliferations.

artículo científico publicado en 2015

DNA degrades during storage in formalin-fixed and paraffin-embedded tissue blocks.

artículo científico publicado en 2017

Detection of microsatellite instability in a panel of solid tumours with the Idylla MSI Test using extracted DNA

artículo científico publicado en 2020

Expression of TFH Markers and Detection of RHOA p.G17V and IDH2 p.R172K/S Mutations in Cutaneous Localizations of Angioimmunoblastic T-Cell Lymphomas

artículo científico publicado en 2017

Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin

artículo científico publicado en 2017

Multiple Ways to Detect IDH2 Mutations in Angioimmunoblastic T-Cell Lymphoma from Immunohistochemistry to Next-Generation Sequencing

scientific article published on 05 July 2018

PD-L1 expression in perihilar and intrahepatic cholangiocarcinoma.

artículo científico publicado en 2017

Polymerase proofreading domain mutations: New opportunities for immunotherapy in hypermutated colorectal cancer beyond MMR deficiency

artículo científico publicado en 2017

Predictive molecular pathology in the time of coronavirus disease (COVID-19) in Europe

artículo científico publicado en 2020

Pro-apoptotic meiogynin A derivatives that target Bcl-xL and Mcl-1.

artículo científico publicado en 2014

Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma

artículo científico publicado en 2016

Targeting STAT6 in PMBL.

artículo científico publicado en 2014

The IDH2 R172K mutation associated with angioimmunoblastic T-cell lymphoma produces 2HG in T cells and impacts lymphoid development

artículo científico publicado en 2016

[Lung adenocarcinoma with concomitant EGFR mutation and ALK rearrangement].

artículo científico publicado en 2016

Lista de obras de

A Study of Hypermethylated Circulating Tumor DNA as a Universal Colorectal Cancer Biomarker

BRAF V600E mutations in bile duct adenomas.

Bile duct adenoma should not be designated as a reactive process.

Constitutive autophagy contributes to resistance to TP53-mediated apoptosis in Epstein-Barr virus-positive latency III B-cell lymphoproliferations.

DNA degrades during storage in formalin-fixed and paraffin-embedded tissue blocks.

Detection of microsatellite instability in a panel of solid tumours with the Idylla MSI Test using extracted DNA

Expression of TFH Markers and Detection of RHOA p.G17V and IDH2 p.R172K/S Mutations in Cutaneous Localizations of Angioimmunoblastic T-Cell Lymphomas

Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin

Multiple Ways to Detect IDH2 Mutations in Angioimmunoblastic T-Cell Lymphoma from Immunohistochemistry to Next-Generation Sequencing

PD-L1 expression in perihilar and intrahepatic cholangiocarcinoma.

Polymerase proofreading domain mutations: New opportunities for immunotherapy in hypermutated colorectal cancer beyond MMR deficiency

Predictive molecular pathology in the time of coronavirus disease (COVID-19) in Europe

Pro-apoptotic meiogynin A derivatives that target Bcl-xL and Mcl-1.

Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma

Targeting STAT6 in PMBL.

The IDH2 R172K mutation associated with angioimmunoblastic T-cell lymphoma produces 2HG in T cells and impacts lymphoid development

[Lung adenocarcinoma with concomitant EGFR mutation and ALK rearrangement].